Phase 1/2 study of the WT1 peptide cancer vaccine WT4869 in patients with myelodysplastic syndrome
暂无分享,去创建一个
M. Ogura | Y. Heike | Y. Miyazaki | K. Ohyashiki | Takahiro Suzuki | Y. Ueda | S. Tagashira | S. Miyakoshi | S. Tsuchiya
暂无分享,去创建一个
M. Ogura | Y. Heike | Y. Miyazaki | K. Ohyashiki | Takahiro Suzuki | Y. Ueda | S. Tagashira | S. Miyakoshi | S. Tsuchiya